Skip to main content

Table 2 Comparison some symptoms according to different symptoms subgroups

From: Gastrointestinal symptoms are associated with a lower risk of hospitalization and mortality and outcomes in COVID-19

 

Total (n = 42,964)

Group 1 (n = 1572)

Group 2 (n = 28,940)

Group 3 (n = 2615)

Group 4 (n = 9837)

P value

Respiratory symptoms

 Cough

21,260(49.48)

–

19,295(66.67)

1965(75.14)

–

0.001

 Respiratory distress

18,317(42.63)

–

16,808(58.07)

1509(57.70)

–

0.001

 Chest pain

1185(2.78)

–

644(2.22)

541(20.68)

–

0.001

Gastrointestinal symptoms

 Stomach ache

688(1.60)

296(18.82)

–

392(14.99)

–

0.001

 Nausea

1781(4.14)

641(40.77)

–

1140(43.59)

–

0.001

 Vomit

1051(2.44)

443(28.18)

–

608(23.25)

–

0.001

 Diarrhea

1198(2.78)

502(31.93)

–

696(26.61)

–

0.001

 Anorexia

1638(3.81)

506(32.18)

–

1132(43.28)

–

0.001

Other symptoms

 Fever

14,475(33.7)

514(32.7)

8588(29.67)

1171(44.78)

4202(42.71)

0.001

 Muscular pain

15,896(37.0)

530(33.7)

9572(33.07)

1260(48.18)

4534(46.09)

0.001

 Loss of consciousness

1188(2.8)

40(2.5)

718(2.48)

85(3.25)

345(3.50)

0.001

 Convulsion

75(0.2)

13(0.82)

29(0.10)

3(0.11)

30(0.30)

0.001

 Headache

1867(5.1)

193(12.27)

722(2.49)

507(19.38)

445(4.52)

0.001

 Dizziness

787(2.15)

123(7.82)

249(0.86)

252(9.63)

163(1.65)

0.001

 Palsy of the limb

172(0.5)

25(1.60)

62(0.21)

36(1.37)

49(0.49)

0.001

 Organ lesion

50(0.15)

7(0.44)

11(0.03)

11(0.42)

21(0.21)

0.001

 Eczema

33(0.09)

7(0.44)

7(0.02)

6(0.22)

13(0.13)

0.001

 Loss sense of smell

1061(2.47)

4(0.002)

800(0.03)

257(0.10)

-

0.001

 Loss sense of taste

727(1.70)

14(0.008)

443(0.02)

216(0.08)

54(0.005)

0.001

  1. Continuous variables were reported as mean ± standard deviations (SD), and qualitative variables were reported as frequency (%). A one-way ANOVA test was used to explore differences between the symptoms subgroups. To comparison of qualitative variables between four groups, the Chi-square test was used
  2. Group 1: Patients with Gastrointestinal symptoms; Group 2: Patients with respiratory symptoms; Group 3: Patients with both symptoms: Group 4: Patients with other symptoms